Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L DeMets

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Circulation|August 7, 2002
Lessons learned from recent cardiovascular clinical trials: Part IDavid L DeMets, Robert M Califf
JAMA|February 18, 2011
A historical perspective on clinical trials innovation and leadership: where have the academics gone?David L DeMets, Robert M Califf
Circulation|August 21, 2002
Principles from clinical trials relevant to clinical practice: Part IRobert M Califf, David L DeMets
JAMA|June 5, 2019
Alternatives to Intention-to-Treat Analyses-ReplyDavid L DeMets, Thomas D Cook
The Journal of Rheumatology|May 3, 2013
Can large simple trials help us understand when and how to use generic drugs for uncommon diseases?Jerry A Molitor, David L Demets
Nature Reviews. Cardiology|June 25, 2014
Prevention: Aspirin in primary prevention needs individual judgementsCharles H Hennekens, David L DeMets
Statistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R Fleming
Circulation|August 15, 2002
Lessons learned from recent cardiovascular clinical trials: Part IIDavid L DeMets, Robert M Califf
Circulation|August 28, 2002
Principles from clinical trials relevant to clinical practice: Part IIRobert M Califf, David L DeMets
The New England Journal of Medicine|October 6, 2016
Data Monitoring Committees - Expect the UnexpectedDavid L DeMets, Susan S Ellenberg
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Circulation|August 7, 2002
Lessons learned from recent cardiovascular clinical trials: Part IDavid L DeMets, Robert M Califf
JAMA|February 18, 2011
A historical perspective on clinical trials innovation and leadership: where have the academics gone?David L DeMets, Robert M Califf
Circulation|August 21, 2002
Principles from clinical trials relevant to clinical practice: Part IRobert M Califf, David L DeMets
JAMA|June 5, 2019
Alternatives to Intention-to-Treat Analyses-ReplyDavid L DeMets, Thomas D Cook
The Journal of Rheumatology|May 3, 2013
Can large simple trials help us understand when and how to use generic drugs for uncommon diseases?Jerry A Molitor, David L Demets
Nature Reviews. Cardiology|June 25, 2014
Prevention: Aspirin in primary prevention needs individual judgementsCharles H Hennekens, David L DeMets
Statistics in Medicine|May 4, 2004
The independent statistician for data monitoring committeesDavid L DeMets, Thomas R Fleming
Circulation|August 15, 2002
Lessons learned from recent cardiovascular clinical trials: Part IIDavid L DeMets, Robert M Califf
Circulation|August 28, 2002
Principles from clinical trials relevant to clinical practice: Part IIRobert M Califf, David L DeMets
The New England Journal of Medicine|October 6, 2016
Data Monitoring Committees - Expect the UnexpectedDavid L DeMets, Susan S Ellenberg
Pageof 10